Sigachi Industries Limited has informed the Exchange regarding a press release dated July 23, 2025, titled "Company is set to commence Research & Development (R&D) operations on 28th July, 2025".
SIGACHI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sigachi Industries Limited will start R&D operations on July 28, 2025, at its newly established R&D Center in Hyderabad. The center will focus on developing a high-value pipeline of Active Pharmaceutical Ingredients (APIs) for global regulated markets, covering end-to-end development from lab-scale to commercialization and regulatory filings. The company has assembled a dedicated team of 32-35 skilled R&D scientists, with plans to target CEP (Certificate of Suitability) filings across priority therapeutic segments. Management described the initiative as a cornerstone of the company's innovation strategy, reinforcing backward integration and positioning Sigachi as a globally competitive API supplier.
This is a positive strategic development signaling investment in innovation and backward integration, which could support long-term growth in higher-margin regulated markets. Near-term stock impact may be limited as R&D benefits typically materialize over several years, but it strengthens the company's competitive positioning in the pharmaceutical ingredients space.